Atlas Trials

Comparing the Efficacy of the LDA, LHAA, and DA Regimens in Young Adults With Low-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Clinical trial NCT07651176 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07651176
Sponsor
First Affiliated Hospital of Zhejiang University
Status
ENROLLING_BY_INVITATION
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaLisaftoclax
Start date
2026-03-01
Primary completion
2029-12-01
Enrollment
267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.